Diligence memo · auto-generated · as of July 2, 2026
Noninvasix, Inc.
Noninvasix, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Noninvasix, Inc. operates in Other Health Care, based in GALVESTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Noninvasix, Inc. has raised $4.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $4.0M on 2020-03-17.
Most recent recorded round closed around 2020-03-17.
Valuation (modeled)modeled
Provath models Noninvasix, Inc. at approximately $98M (range $3.3M–$768M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.73× the median modeled value of Seed Other Health Care companies in 2019–2021 (211 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 6.3 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 60% of Other Health Care peers (5377 compared).
Modeled value ranks above 79% of those peers.
Closest niche peers: Crossroads at Delta Memory, CPIV Haven Holdings, LLC, Cane Ip Key Holdings, Llc, Hospi Corp, Functional Fluidics Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.